🇺🇸 FDA
Pipeline program

NK cell perfusion group

SC2025-0013-01

Phase 2 mab active

Quick answer

NK cell perfusion group for Abortion, Missed is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Abortion, Missed
Phase
Phase 2
Modality
mab
Status
active

Clinical trials